SPARC Update on Innovation Effort
MUMBAI, India--(BUSINESS WIRE)--In a detailed presentation recently, Sun Pharma Advanced Research Company Ltd. (SPARC, NSE: SPARC, BSE: 532872) management shared updates for its Novel Drug Delivery System (NDDS) and New Chemical Entity (NCE) programs. Information on products based on 7 NDDS platform technologies and 4 promising NCEs were discussed.